• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

tetano

Editor, Senior Moderator
J Infect. 2020 May 7. pii: S0163-4453(20)30244-9. doi: 10.1016/j.jinf.2020.04.033. [Epub ahead of print]
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.


Demey B[SUP]1[/SUP], Daher N[SUP]2[/SUP], Fran?ois C[SUP]1[/SUP], Lanoix JP[SUP]3[/SUP], Duverlie G[SUP]1[/SUP], Castelain S[SUP]1[/SUP], Brochot E[SUP]4[/SUP].

Author information




Abstract

In order to fight the SARS-CoV-2 pandemic infection, there is a growing need and demand for diagnostic tools that are complementary and different from the RT-PCR currently in use. Multiple serological tests are or will be very soon available but need to be evaluated and validated. We have thus tested 4 immunochromatographic tests for the detection of antibodies to SARS-CoV-2. In addition, we assessed the kinetics of antibody appearance using these assays in 22 patients after they were tested positive by RT-PCR. We observed great heterogeneity in antiboy detection post-symptom onset. The median antibody detection time was between 8 and 10 days according to the manufacturers. All the tests showed a sensitivity of 60 to 80% on day 10 and 100% on day 15. In addition, a single cross-reaction was observed with other human coronavirus infections. Thus, immunochromatographic tests for the detection of anti-SARS-CoV-2 antibodies may have their place for the diagnostic panel of COVID-19.
Copyright ? 2020 Elsevier Ltd. All rights reserved.



KEYWORDS:

Antibody; COVID-19; Lateral flow assay; SARS-CoV-2


PMID:32389784DOI:10.1016/j.jinf.2020.04.033
 
Back
Top